FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2316914859> ?p ?o ?g. }

• W2316914859 endingPage "635" @default.
• W2316914859 startingPage "627" @default.
• W2316914859 abstract "It has been postulated that inhaled long acting beta-agonists (LABAs) when used as monotherapy in asthma may increase the incidence of asthma related deaths, intubations and hospitalizations, but concomitant use of inhaled corticosteroids (ICS) may modify this effect.To assess the safety of formoterol in patients with asthma using ICS.We conducted a systematic review and meta-analysis of parallel group, blinded, randomized controlled trials with at least 12 weeks of treatment examining the impact of twice a day formoterol on asthma-related and total morbidity and mortality in patients concurrently using ICS. Our main analysis considering impact of LABAs (salmeterol and formoterol) has already been published. In this report we present detailed information from studies investigating use of twice daily formoterol among patients receiving ICS.The search yielded 16 relevant studies included in this analysis. Among over 10,000 participants (5,996 taking formoterol with over 4,000 patient-years observation in formoterol groups) there were 2 asthma-related deaths (both in formoterol groups) and no asthma-related non-fatal intubations. The risk of asthma-related hospitalizations (odds ratio [OR] 0.59, 95% CI 0.37-0.93) and asthma-related serious adverse events (mostly hospitalizations) [OR 0.58, 95% CI 0.37-0.91] were significantly lower in patients on formoterol and ICS compared to patients on ICS alone. The OR for total mortality was 1.22, 95% CI 0.38-3.90, reflecting 7 deaths in formoterol groups and 3 deaths in control groups respectively.In patients with asthma using inhaled corticosteroids formoterol decreased the risk of asthma-related hospitalizations. There were too few asthma-related deaths and intubations to establish formoterol's relative impact on these outcomes." @default.
• W2316914859 created "2016-06-24" @default.
• W2316914859 creator A5006832289 @default.
• W2316914859 creator A5009413838 @default.
• W2316914859 creator A5013315390 @default.
• W2316914859 creator A5026242254 @default.
• W2316914859 creator A5029801001 @default.
• W2316914859 creator A5031717153 @default.
• W2316914859 creator A5043384949 @default.
• W2316914859 creator A5046215571 @default.
• W2316914859 creator A5052117957 @default.
• W2316914859 creator A5058199788 @default.
• W2316914859 creator A5071868716 @default.
• W2316914859 creator A5090489081 @default.
• W2316914859 date "2008-11-01" @default.
• W2316914859 modified "2023-10-18" @default.
• W2316914859 title "The safety of formoterol among patients with asthma using inhaled corticosteroids. Systematic review and meta‑analysis" @default.
• W2316914859 cites W1795103282 @default.
• W2316914859 cites W1965973512 @default.
• W2316914859 cites W1972813104 @default.
• W2316914859 cites W1981748384 @default.
• W2316914859 cites W2085294706 @default.
• W2316914859 cites W2087666617 @default.
• W2316914859 cites W2096043817 @default.
• W2316914859 cites W2098188679 @default.
• W2316914859 cites W2099652899 @default.
• W2316914859 cites W2100502270 @default.
• W2316914859 cites W2102627080 @default.
• W2316914859 cites W2107328434 @default.
• W2316914859 cites W2110658984 @default.
• W2316914859 cites W2113552278 @default.
• W2316914859 cites W2140539644 @default.
• W2316914859 cites W2313479281 @default.
• W2316914859 cites W3142424398 @default.
• W2316914859 doi "https://doi.org/10.20452/pamw.508" @default.
• W2316914859 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19140566" @default.
• W2316914859 hasPublicationYear "2008" @default.
• W2316914859 type Work @default.
• W2316914859 sameAs 2316914859 @default.
• W2316914859 citedByCount "10" @default.
• W2316914859 countsByYear W23169148592012 @default.
• W2316914859 countsByYear W23169148592013 @default.
• W2316914859 countsByYear W23169148592015 @default.
• W2316914859 countsByYear W23169148592018 @default.
• W2316914859 countsByYear W23169148592019 @default.
• W2316914859 crossrefType "journal-article" @default.
• W2316914859 hasAuthorship W2316914859A5006832289 @default.
• W2316914859 hasAuthorship W2316914859A5009413838 @default.
• W2316914859 hasAuthorship W2316914859A5013315390 @default.
• W2316914859 hasAuthorship W2316914859A5026242254 @default.
• W2316914859 hasAuthorship W2316914859A5029801001 @default.
• W2316914859 hasAuthorship W2316914859A5031717153 @default.
• W2316914859 hasAuthorship W2316914859A5043384949 @default.
• W2316914859 hasAuthorship W2316914859A5046215571 @default.
• W2316914859 hasAuthorship W2316914859A5052117957 @default.
• W2316914859 hasAuthorship W2316914859A5058199788 @default.
• W2316914859 hasAuthorship W2316914859A5071868716 @default.
• W2316914859 hasAuthorship W2316914859A5090489081 @default.
• W2316914859 hasBestOaLocation W23169148592 @default.
• W2316914859 hasConcept C120665830 @default.
• W2316914859 hasConcept C121332964 @default.
• W2316914859 hasConcept C126322002 @default.
• W2316914859 hasConcept C156957248 @default.
• W2316914859 hasConcept C168563851 @default.
• W2316914859 hasConcept C197934379 @default.
• W2316914859 hasConcept C2776042228 @default.
• W2316914859 hasConcept C2776136866 @default.
• W2316914859 hasConcept C2776719499 @default.
• W2316914859 hasConcept C2779028295 @default.
• W2316914859 hasConcept C2779871671 @default.
• W2316914859 hasConcept C2909086917 @default.
• W2316914859 hasConcept C2991922776 @default.
• W2316914859 hasConcept C42219234 @default.
• W2316914859 hasConcept C61511704 @default.
• W2316914859 hasConcept C71924100 @default.
• W2316914859 hasConcept C95190672 @default.
• W2316914859 hasConceptScore W2316914859C120665830 @default.
• W2316914859 hasConceptScore W2316914859C121332964 @default.
• W2316914859 hasConceptScore W2316914859C126322002 @default.
• W2316914859 hasConceptScore W2316914859C156957248 @default.
• W2316914859 hasConceptScore W2316914859C168563851 @default.
• W2316914859 hasConceptScore W2316914859C197934379 @default.
• W2316914859 hasConceptScore W2316914859C2776042228 @default.
• W2316914859 hasConceptScore W2316914859C2776136866 @default.
• W2316914859 hasConceptScore W2316914859C2776719499 @default.
• W2316914859 hasConceptScore W2316914859C2779028295 @default.
• W2316914859 hasConceptScore W2316914859C2779871671 @default.
• W2316914859 hasConceptScore W2316914859C2909086917 @default.
• W2316914859 hasConceptScore W2316914859C2991922776 @default.
• W2316914859 hasConceptScore W2316914859C42219234 @default.
• W2316914859 hasConceptScore W2316914859C61511704 @default.
• W2316914859 hasConceptScore W2316914859C71924100 @default.
• W2316914859 hasConceptScore W2316914859C95190672 @default.
• W2316914859 hasIssue "11" @default.
• W2316914859 hasLocation W23169148591 @default.
• W2316914859 hasLocation W23169148592 @default.
• W2316914859 hasLocation W23169148593 @default.
• W2316914859 hasLocation W23169148594 @default.

• next